Arya raises $18M Series A to advance AI agents for post-acute care.
One year ago, we led Arya Health’s $4 million seed round because we saw an intersection of three major forces reshaping healthcare operations: the ongoing labor crisis, the lack of intelligent infrastructure in post-acute and home-based care, and the maturation of AI-native enterprise software. With Arya’s new $18.2 million Series A announcement, that conviction has only deepened — and the broader market is now catching up.
When we first met the team, Arya was tackling one of the most acute pain points in healthcare: managing a large, fragmented, and overburdened workforce. Providers across skilled nursing, home health, and behavioral health were struggling with staffing shortages, burnout, compliance requirements, and razor-thin margins. In a system employing more than 17 million people, even small efficiency gains translate to enormous impact.
What stood out immediately was Arya’s approach. Rather than building a generic HR or workforce management tool, Arya built an AI-native operations layer for healthcare services — an adaptive system that automates scheduling, onboarding, credentialing, and compliance, while learning from each organization’s unique workflows. The product promised not just incremental efficiency, but structural change: fewer administrative bottlenecks, better shift coverage, and ultimately higher patient-care continuity.
Since our investment, Arya’s progress has been striking. The company reports a six-fold increase in revenue, with customers seeing scheduling improvements of over 40% and faster fill rates of more than 50%. Those metrics translate to real economic outcomes for care providers — reducing agency costs, improving utilization, and strengthening retention in a sector where every percentage point matters.
The market backdrop for Arya’s platform is enormous. The U.S. post-acute care market alone is approaching $500 billion this year and expected to nearly double over the next decade. Beneath that, the healthcare workforce management software segment — the layer Arya is automating — is growing from roughly $2 billion in 2023 to over $4 billion by 2030, expanding at more than 10% annually. And because Arya’s architecture is modular and extensible, the company can move horizontally into other labor-intensive verticals within healthcare over time.
The new Series A validates this thesis. It provides capital to deepen product capabilities, expand into adjacent markets, and scale go-to-market teams. More importantly, it signals a growing recognition that healthcare operations can no longer be managed through manual workflows and fragmented legacy systems. Automation isn’t a luxury — it’s a necessity.
As seed investors, our belief was that Arya could become the operating system for healthcare labor. That conviction looks stronger than ever. The company is executing against a massive, structural opportunity with measurable ROI, an exceptional founding team, and strong early momentum. If Arya continues on its current trajectory, it won’t just build a valuable company — it will redefine how healthcare organizations function at their core.
We’re proud to have backed Arya early, and we’re even more excited for what comes next.